HHS Probes $120M in Gender Treatments for Minors

The Trump Administration has launched a criminal investigation after a new federal report alleged that hospitals billed nearly $120 million for gender-related medical procedures and drugs provided to minors since 2019.

The 64-page Department of Health and Human Services report, titled “Wolves in White Coats,” alleges that political pressure and financial incentives helped fuel the rapid expansion of pediatric gender medicine.

Watchdog analyses cited by HHS identified more than 5,500 surgical procedures and 8,500 courses of hormones or puberty blockers billed by hospitals and clinics during the period examined.

Some of the country’s most prominent children’s hospitals and medical systems recorded the highest billings, according to the report, including Boston Children’s Hospital and Mount Sinai Medical Center in New York.

“The policies of President Donald J. Trump have discouraged hospitals from providing these interventions. But how was this madness allowed to fester under America’s hospital system?” the report asks.

“This report concludes that a litany of political and financial incentives led providers to offer, and indeed urge, the prescription of sex-rejection drugs and surgeries for minors.”

HHS argues that pediatric departments have historically generated lower profit margins than many adult specialties. Gender clinics, the agency alleges, offered hospitals a new source of recurring revenue through consultations, medications, monitoring and surgical care.

“Gender clinics changed that calculus by introducing a novel source of revenue: they promised a new stream of continuous revenue for pediatrics, endocrinology, and surgical specialties by taking physiologically healthy young people, who otherwise would not need to seek medical attention, and rendering them dependent for life on the medical system,” the report states.

The report also raises potential billing-fraud concerns.

HHS accuses some providers of improperly using diagnostic codes associated with endocrine disorders or precocious puberty when billing insurers for gender-related treatments. The agency says the coding may have been used to secure insurance coverage or conceal the nature of a patient’s care.

Full report over at The New York Post:

Hospitals, doctors got rich through shady gender-care billing tactics – and taking advantage of kids: damning report https://t.co/v4askubHDD pic.twitter.com/qpvJPh5a5a

— New York Post (@nypost) August 13, 2026